Swiss National Bank’s Alpine Immune Sciences Inc ALPN Stock Holding History

Swiss National Bank’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-63,500	Closed	-$2.52M	–	2534
2024 Q1	$2.52M	Buy	63,500 +6,300	+11%	+$186K	﹤0.01%	1711
2023 Q4	$1.09M	Buy	57,200 +15,000	+36%	+$208K	﹤0.01%	2190
2023 Q3	$483K	Buy	+42,200	New	+$519K	﹤0.01%	2513

Swiss National Bank's ALPN Position: Q2 2024 in Review

Swiss National Bank sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 63,500 shares — an estimated $2.52M sold.

Swiss National Bank first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $2.52M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Swiss National Bank reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Swiss National Bank sold 63,500 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.52M.
Swiss National Bank first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
Swiss National Bank's Alpine Immune Sciences Inc position peaked at $2.52M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.